CNGG.F Stock Overview
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Cann Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.12 |
| 52 Week High | AU$0.23 |
| 52 Week Low | AU$0.086 |
| Beta | 1.13 |
| 1 Month Change | 11.41% |
| 3 Month Change | n/a |
| 1 Year Change | -51.93% |
| 3 Year Change | -85.34% |
| 5 Year Change | -94.91% |
| Change since IPO | -95.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| CNGG.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -2.7% | 0.06% |
| 1Y | -51.9% | -4.9% | -0.7% |
Return vs Industry: CNGG.F underperformed the US Pharmaceuticals industry which returned -4.9% over the past year.
Return vs Market: CNGG.F underperformed the US Market which returned -0.7% over the past year.
Price Volatility
| CNGG.F volatility | |
|---|---|
| CNGG.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 10.6% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 15.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: Insufficient data to determine CNGG.F's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine CNGG.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | n/a | Peter Koetsier | https://www.canngrouplimited.com |
Cann Group Limited engages in the breeding, cultivation, production, manufacturing, clinical evaluation, and supplying medicinal cannabis for sale and use within Australia and for overseas export markets. It licenses to undertake research and to cultivate cannabis for human medicinal and research purposes. The company was founded in 2014 and is based in Port Melbourne, Australia.
Cann Group Limited Fundamentals Summary
| CNGG.F fundamental statistics | |
|---|---|
| Market Cap | US$43.22m |
| Earnings (TTM) | -US$24.23m |
| Revenue (TTM) | US$9.42m |
4.5x
P/S Ratio-1.7x
P/E RatioIs CNGG.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| CNGG.F income statement (TTM) | |
|---|---|
| Revenue | AU$14.40m |
| Cost of Revenue | AU$0 |
| Gross Profit | AU$14.40m |
| Other Expenses | AU$51.43m |
| Earnings | -AU$37.03m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.095 |
| Gross Margin | 100.00% |
| Net Profit Margin | -257.18% |
| Debt/Equity Ratio | 78.2% |
How did CNGG.F perform over the long term?
See historical performance and comparison